Direxion Daily S&P 500 High Beta Bear 3X Shares
HIBS News Today: Stay Updated with the Latest Direxion Daily S&P 500 High Beta Bear 3X Shares News in Real Time
Find HIBS news now at Meyka AI. Stay informed with the latest Direxion Daily S&P 500 High Beta Bear 3X Shares stocks updates, including price news, market analysis, and expert insights.

COST Stock Today: Sales Top Estimates, Shares Dip After Q2 — March 5
Costco stock slips after Q2 despite a sales and EPS beat. Same-store sales rose 7.4%. We break down results, valuation, and key price levels Canadian investors should watch today.

16.48% Intraday Gain: Okano Valve (6492.T) JPX 06 Mar 2026, volume-led momentum
6492.T stock jumps 16.48% intraday to JPY 10600.00 on heavy volume; see Meyka AI forecast and analyst context

Pre-market 06 Mar 2026: Cathay Pacific (0293.HK HKSE) HK$12.98 ahead of earnings
0293.HK stock trades HK$12.98 pre-market on 06 Mar 2026 ahead of March earnings; Meyka AI forecast and grade inside

19.10% jump: Healwell AI (6H90.SG STU) at €0.58 on 06 Mar 2026: watch resistance
6H90.SG stock rallies 19.10% to €0.58 on 06 Mar 2026; short-term momentum vs. model forecast

BKW.SI stock at S$0.11 pre-market on 06 Mar 2026: Oversold bounce set-up may offer short-term recovery
BKW.SI stock pre-market S$0.11 on 06 Mar 2026; oversold bounce setup with short targets and Meyka AI forecast

Down 50.00% intraday 06 Mar 2026: SRN.AX Surefire (ASX) liquidity and valuation alert
SRN.AX stock plunges 50.00% intraday on 06 Mar 2026; analysis of liquidity, valuation and Meyka AI forecast

USD 0.0201 PDPG Performance Drink Group, Inc. (PNK) 06 Mar 2026: Oversold bounce target $0.06
PDPG stock at USD 0.0201 on 06 Mar 2026; oversold bounce setup with heavy volume and defined price targets

Jefferies Maintains Buy on National Vision Holdings (EYE) March 2026
Jefferies maintained Buy and raised PT to $40 in March 2026 in the latest EYE analyst rating update

William Blair Maintains Outperform on SGHT Sight Sciences, Inc. March 2026
William Blair maintains Outperform on SGHT; our take on the SGHT analyst rating and investor implications